~" Experimental models of meningeal gliomatosis (MG) have been produced by intracisternal inoculation of rat C6 and 9L glioma cells into Wistar and Fischer 344 rats, respectively. Tumor growth was steady and rapid in both MG models when more than l06 tumor cells were implanted. The median survival time of the rats inoculated with tumor cells was inversely related to the number of the cells inoculated. The clinicopathological features observed in both MG models were similar to those seen in diffuse leptomeningeal involvement of gliomas in humans. The models may be useful for investigating the pathophysiology of MG and for the determination of the efficacy of chemotherapeutic agents in brain-tumor chemotherapy.
M
ENINGEAL gliomatosis (MG) has been thought to be comparatively rare; however, its incidence has tended to increase with prolongation of the survival time of brain-tumor patients. 17 Pathologically, MG is the multifocal or diffuse infiltration of tumor cells into the subarachnoid space. Although the incidence of MG in brain-tumor patients is reported as between 10% and 20%, only a few series of MG cases have been published and its actual incidence is unknown. 2'3"7 No effective treatment has been described and the pathophysiology has not been elucidated. Recently, MG has been more frequently found to be associated with various chemotherapeutic treatments; such recurrent tumors are often clinically refractory to the drugs and radiotherapy previously employed. In order to study the treatment and pathophysiology of MG systematically, experimental models of MG have been developed in rats without causing mechanical injury to the brain.
Materials and Methods

Animal and Tumor Preparation
Male Wistar and Fischer 344 rats, each weighing approximately I00 gm, were used in these experiments. Wistar rats were the carder of the C6 glioma, and Fischer 344 rats bore the 9L glioma.
The C6 and 9L glioma cells were cultured in Eagle's minimum essential medium supplemented with 10% heat-inactivated fetal bovine serum, 10 #M 2-mercaptoethanol, penicillin base (50 U/ml), and streptomycin base (50 #g/ml).* Cells were transferred to fresh medium every 3 days to sustain exponential growth.
Preparation of MG Models
Diluted cell suspension (0.1 ml) containing 1 x 104, 1 • 105, 1 • 10 6, 1 x 107, or 1 • 10 s viable C6 or 9L glioma cells was transplanted percutaneously via a No. 27 needle into the cisterna magna of Wistar or Fischer 344 rats, respectively, under ether anesthesia. Each concentration of tumor cells was given to 10 rats. All of the 10 groups of 10 rats were observed daily, and the changes in body weight were recorded until the rats died of the disease. At regular time intervals from 2 hours to 15 days after the inoculation of 1 • 107 tumor cells, two rats were sacrificed for histological examination. When a rat died or was sacrificed, the intact skull and vertebral column were freed from overlying soft tissue, fixed in 10% formalin, and then decalcified. Coronal blocks, approximately 3 mm thick, were cut through the skull and brain. The vertebral column and spinal cord were cut in either transverse or longitudinal planes. Histological sections were prepared from each block of tissue, and stained with hematoxylin and eosin.
Results
Physical Findings
All of the rats that received concentrations greater than 1 x 107 of either C6 (C6-MG) or 9L (9L-MG) glioma cells died within 20 days after inoculation. The median survival time of each model was inversely related to the number of cells inoculated (Fig. 1) . In suspensions of less than 1 • 105, tumor cells did not grow in either the Wistar or the Fischer 344 rats.
Clinical signs began to appear on the 3rd or 4th day after tumor inoculation and rapidly progressed according to the stages indicated in Table 1 . Slight weight loss was observed first, followed 2 or 3 days later by a decrease in activity and nervous reactions such as raising of hairs and a tendency toward violence. Between 7 and 9 days after tumor inoculation, pigmentation around the eyes and nose was noticed in addition to paresis of the hind legs which progressed to paralysis; however, typically no paresis or paralysis of the forelegs occurred. Muscular atrophy of the lower extremities became noticeable at this time. Ten or 11 days after tumor inoculation, the weight of the MG rats had decreased to 60% or 70% of baseline. Urinary and fecal incontinence was also observed at this stage. All MG rats going through those stages, as stated above, died within 20 days after inoculation, and the mean survival time (_+ standard error of the mean) of each C6-MG and 9L-MG rat was 14.3 __+ 2.94 and 14.3 ___ 3.05 days, respectively.
Pathological Findings
Pathological findings of both MG rat models were almost the same on macroscopic and histological ex-
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amination. Macroscopically, the spinal cord was diffusely invaded by the tumor, and tumor nodules were also occasionally found in the subarachnoid space between the cervical cord and the cauda equina. In addition, the leptomeninges of the longitudinal fissure and basal cistern were observed to be opaque and thickened.
Microscopically, 2 hours after tumor inoculation the tumor cells were already found in the longitudinal fissure, chiasmatic infundibular region, pontine cistern, ambient cistern, cerebellopontine cistern, and the subarachnoid space of the spinal cord except for the cauda equina ( Table 2) . One day after implantation of the tumor cells, a few layers of tumor cells were noted throughout the surface of the brain and the spinal cord, but not at the cerebral convexity or the cerebellar hemisphere. Aggregates of tumor cells forming spheroids were found attached to the ventricular wall and the leptomeninges of the subarachnoid space 3 days after tumor inoculation (Fig. 2 left) .
About 2 or 3 days following this stage, multiple layers of tumor cells had grown on the surface of the brain and the spinal cord extending into the parenchyma through the perivascular space of the penetrating vessels, and the Virchow-Robin spaces were invaded by tumor (Fig. 2 right) . Although direct parenchymal invasion of the tumor was also observed through the disrupted pia on the 7th or 8th day, parenchymal infiltration of the tumor more likely occurred through the perivascular space than directly through the pial surface by breaching the pia.
Tumor invasion into the cranial nerves was first observed on the 2nd day, and by the 5th day tumor had involved all the cranial nerves. On the 10th day, the tumor had progressively invaded the quadrigeminal and 
t c i s t e r n s , a n d t h e m i d b r a i n w a s h e a v i l y e n c a s e d b y t u m o r cells (Fig. 3). A l l o f t h e M G r a t s d e m o n s t r a t e d t u m o r i n v a s i o n o f t h e f o u r t h v e n t r i c l e t h r o u g h t h
e f o r a m i n a o f L u s c h k a a n d M a g e n d i e , a n d a p p r o x i m a t e l y 7 0 % o f t h e r a t s h a d t u m o r i n v o l v e m e n t o f t h e l a t e r a l a * Two rats were sacrificed at each lime stated. Involvement: 0 = no rats; + = one rat; + + = two rats. t Findings in 20 rats followed until death from the tumor.
FIG. 2. Left: P h o t o m i c r o g r a p h s h o w i n g aggregated cells f o r m i n g s p h e r o i d s in the lateral ventricle 3 d a y s after t u m o r cell i n o c u l a t i o n . H & E, x 108. Right: P h o t o m i c r o g r a p h s h o w i n g p e r i v a s c u l a r e x t e n s i o n o f
t u m o r into the p a r e n c h y m a f r o m overlying m e n i n g e a l infiltration 6 days after i m p l a n t a t i o n . T u m o r h a s e x t e n d e d along p e n e t r a t i n g vessels to e n t e r the u n d e r l y i n g brain tissue. however, direct invasion into the inferior horn of the lateral ventricles by the tumor rupturing through the tela choroidea, which separates the ventricle from the hippocampal sulcus, was also observed in a few cases.
Hydrocephalus was seen in approximately 95% of the M G rats that were followed until they died of the disease (Table 2 ), but the degree of hydrocephalus did not always correlate with the amount of tumor invasion of the fourth ventricular region. This indicates another possible mechanism producing hydrocephalus; that is, alteration in the absorption of arachnoid villi of the superior sagittal sinus resulting from tumor infiltration into the villi.
Diffusely spread t u m o r layers and tumor nodules were observed in the subarachnoid space of the spinal cord by the 5th day after tumor inoculation, It was characteristic that the t u m o r density was greater over the dorsal surface than over the ventral surface of the spinal cord (Fig. 4 left) . At the level of the cauda equina, epidural tumor infiltration was prominent (Fig. 4 right) .
Neither metastasis nor tumor infiltration into other organs was seen in the 10 rats that were subjected to complete autopsy.
Discussion
It has been believed that malignant brain tumors spread diffusely and invade the parenchyma without multifocal occurrence or diffuse leptomeningeal dissemination (meningeal gliomatosis); 1 however, the incidence of meningeal dissemination of tumors has lately been reported as comparatively high. 4'16A7 Although recent developments in therapy with prolongation of survival time of brain-tumor patients may have increased the incidence of MG, a systematic investigation of the pathophysiology and treatment of M G has not been done.
In the field of leukemia or breast cancer, animal models of meningeal leukemia TM and meningeal carcinomatosis ~4 have been developed, and systematic study of these diseases has advanced to the point where data from these animal models can be applied in actual clinical treatment. To facilitate a study of the treatment and pathophysiology of MG, rat M G models have been developed by using cloned C6 and 9L glioma cell lines. The pathophysiology of these M G models appears similar to that of human M G in the following aspects: tumor infiltration was prominent in the basal cistern and the cauda equina; tumor density was greater over the dorsal surface than over the ventral surface; and there was a high incidence of hydrocephalus.
The symptomatology observed in M G rats resembled that seen in humans, except that the pigmentation around the eyes and nose seen in rats is not observed in humans. The mechanism responsible for this pigmentation is presumably venous bleeding caused by obstruction of major veins which, in turn, was created by rapidly increased intracranial pressure. The related pathological findings in MG rats were the expansion and the eruption of the small veins of the mucous membrane of the nose and conjunctiva. The similarity of the pathological findings of rat MG to those of human MG suggests that, with some exceptions, these MG models can be regarded as useful experimental brain-tumor models to investigate the pathophysiology and treatment of human MG.
These models appear to have the following advantages: 1) due to the simplicity of the method, a large number of animal models can be produced in a short time; 2) the animals are large enough to have the drugs administered intravenously or intrathecally; 3) 100% successful tumor implantation can be obtained with more than 10 6 cell densities; and 4) the survival time of MG rats is well defined within a given period, and the mean survival time is long enough to allow modes of therapy to be tested.
In the past, it was not until the symptoms had occurred and diagnosis was made by CSF cytology that MG was found. More recently, MG can be coincidentally detected by computerized tomography (CT). In our clinical experience between 1982 and 1984, evidence of MG was detected in nine (24%) of 38 patients with glioma (including anaplastic astrocytoma and glioblastoma). Among these MG patients, five cases (56%) were identified by CT, indicating that CT is useful in detecting MG at its early stage. On the other hand, the mean survival time of these MG patients was only 16 weeks (range 3 to 40 weeks) after diagnosis followed by intensive therapy with radiation and chemotherapeutic agents. This demonstrates the difficulty in treating MG, which may relate to the acquisition of resistance to chemotherapeutic agents, considering that MG almost always occurs after previous treatment. Another reason for the poor prognosis may be that treatment has not been selected corresponding to the stages of MG reached.
As a measure of the efficacy of chemotherapeutic agents, in vitro chemosensitivity assay systems have been established and tested clinically. 6,8-~~
The in vitro results do not always correlate to brain tumors in vivo because of the effect of the blood-brain barrier in the latter situation. Various brain-tumor models have been introduced and used to evaluate chemotherapy; however, many of these models have failed to preserve the blood-brain barrier, which is a major problem in brain-tumor chemotherapy. The MG models presented herein can be considered as brain-tumor models in which the blood-brain barrier is comparatively intact. 16 Thus, these MG models may be useful, not only as a chemosensitivity assay model but also in studying the pathophysiology and systematic treatment of MG.
